Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Microsoft
MSFT
|
+$351M |
| 2 |
Netflix
NFLX
|
+$343M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$293M |
| 4 |
Nike
NKE
|
+$186M |
| 5 |
Delta Air Lines
DAL
|
+$177M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$1.33B |
| 2 |
Tesla
TSLA
|
+$344M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$306M |
| 4 |
NVIDIA
NVDA
|
+$281M |
| 5 |
Boeing
BA
|
+$251M |
Sector Composition
| 1 | Technology | 19.27% |
| 2 | Healthcare | 18.45% |
| 3 | Consumer Discretionary | 12.35% |
| 4 | Consumer Staples | 10.15% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMTI
3426
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $44K | ﹤0.01% |
282,187
+8,900
| +3% | +$1.39K |
|
3427
Maris-Tech
MTEK
$25.6M
| $43K | ﹤0.01% |
+45,395
| New | +$43K |
|
3428
NRX Pharmaceuticals
NRXP
$68.5M
| $43K | ﹤0.01% |
16,378
+13,028
| +389% | +$34.2K |
|
3429
Presidio Property Trust
SQFT
$7.64M
| $43K | ﹤0.01% |
5,445
+340
| +7% | +$2.69K |
|
3430
US Gold Corp
USAU
$213M
| $43K | ﹤0.01% |
+13,800
| New | +$43K |
|
3431
Exicure
XCUR
$22.7M
| $42K | ﹤0.01% |
11,600
-980
| -8% | -$3.55K |
|
3432
Elutia
ELUT
$55.5M
| $42K | ﹤0.01% |
29,516
-30,900
| -51% | -$44K |
|
|
BCLI
3433
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $41K | ﹤0.01% |
13,573
-214
| -2% | -$646 |
|
3434
Butterfly Network
BFLY
$390M
| $41K | ﹤0.01% |
+34,800
| New | +$41K |
|
3435
Codere Online
CDRO
$368M
| $41K | ﹤0.01% |
13,700
-2,114
| -13% | -$6.33K |
|
3436
Oragenics
OGEN
$4.75M
| $40K | ﹤0.01% |
451
+27
| +6% | +$2.4K |
|
|
LABP
3437
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
| $40K | ﹤0.01% |
+10,260
| New | +$40K |
|
|
FENG
3438
Phoenix New Media
FENG
$31.5M
| $39K | ﹤0.01% |
31,131
| – | – |
|
|
WRN
3439
Western Copper and Gold
WRN
$323M
| $39K | ﹤0.01% |
28,633
-107,067
| -79% | -$146K |
|
3440
Iterum Therapeutics
ITRM
$31.7M
| $38K | ﹤0.01% |
46,922
+4,138
| +10% | +$3.35K |
|
|
IMDX
3441
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$91M
| $38K | ﹤0.01% |
12,218
+5,313
| +77% | +$16.5K |
|
3442
Prenetics Global
PRE
$115M
| $37K | ﹤0.01% |
5,053
+1,333
| +36% | +$9.76K |
|
3443
SAB Biotherapeutics
SABS
$22.1M
| $37K | ﹤0.01% |
5,810
+370
| +7% | +$2.36K |
|
3444
Xcel Brands
XELB
$6.95M
| $37K | ﹤0.01% |
+3,570
| New | +$37K |
|
|
BFI
3445
DELISTED
BurgerFi International, Inc. Common Stock
BFI
| $37K | ﹤0.01% |
32,100
-2,700
| -8% | -$3.11K |
|
3446
Forian
FORA
$68.8M
| $36K | ﹤0.01% |
16,200
-715
| -4% | -$1.59K |
|
|
ITRG
3447
Integra Resources
ITRG
$450M
| $36K | ﹤0.01% |
42,580
-54,613
| -56% | -$46.2K |
|
3448
Neonode
NEON
$72M
| $36K | ﹤0.01% |
22,190
-34,410
| -61% | -$55.8K |
|
3449
SPAR Group
SGRP
$27M
| $36K | ﹤0.01% |
37,200
-1,000
| -3% | -$968 |
|
|
THM
3450
International Tower Hill Mines
THM
$326M
| $36K | ﹤0.01% |
101,458
-43,731
| -30% | -$15.5K |
|